Click HERE for Coronavirus COVID-19 Links for the UCSF Cancer Community

The Radical Compassion of Awake Brain Surgery

UCSF Magazine spotlights Dr. Shawn Hervey-Jumper, a neurosurgeon who specializes in awake brain surgery, in which patients are alert and engaged during parts of the procedure in order to prevent severe brain damage

Mission: A Tobacco-Free World

Q&A with Pamela Ling, director of UCSF’s Center for Tobacco Control Research and Education

Hala Borno, MD, Resident Alum : Ensuring clinical trials serve patients of color

Aggressive Surgery Increases Survival with Low-Grade Brain Tumors

The transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much as possible soon after diagnosis, according to the results of a study led by UC San Francisco.

Year in Review: 2022

This has been a year of innovation and achievement at the Helen Diller Family Comprehensive Cancer Center. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, community groups, and government and industry partners to improve the quality of cancer prevention, treatment, and survivorship. As the year winds down, we take a moment to reflect on some highlights.

Sketches cover a hood shield in UCSF chemist Kevan Shokat’s lab

UCSF Researchers Uncover New Pathway for Molecular Cancer Drug Therapies

Bitopic Inhibitors May Lay Foundation for New Approach to Disease Treatment

Rethinking How Cancer Cells Evade Targeted Therapy

UCSF Researchers Identify the Cellular Source of Recurrent Glioma

Killing Pancreatic Cancer with T Cells that Supercharge Themselves

Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Within the Tumor

Beyond CAR-T: Re-engineering Cells into Life-saving Therapies

Dr. Lawrence Fong, Cancer Immunotherapy Program lead at UCSF, joins patients advocates to discuss the advantages and challenges of harnessing the power of cellular therapy in the latest CureTalks podcast.

How AI Found the Words to Kill Cancer Cells

Using new machine learning techniques, researchers at UC San Francisco, in collaboration with a team at IBM Research, have developed a virtual molecular library of thousands of “command sentences” for cells, based on combinations of “words” that guided engineered immune cells to seek out and tirelessly kill cancer cells.

Val Weaver reviews scientific poster at UCSF.

More than 30 Researchers Among Most Influential

Thirty-six UC San Francisco researchers, almost half of whom are Cancer Center members, rank in the top 1 percent for impact in their fields, according to a new analysis of research citations.